YS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the Meeting
YS Biopharma Co., Ltd. (Nasdaq: YS) (“YS Biopharma” or the “Company”), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and...
Posted On 01 Feb 2024